Literature DB >> 24574708

Is irritable bowel syndrome an organic disorder?

Magdy El-Salhy1, Doris Gundersen1, Odd Helge Gilja1, Jan Gunnar Hatlebakk1, Trygve Hausken1.   

Abstract

Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that is generally considered to be functional because there appears to be no associated anatomical defect. Stress and psychological factors are thought to play an important role in IBS. The gut neuroendocrine system (NES), which regulates all functions of the gastrointestinal tract, consists of endocrine cells that are scattered among the epithelial cells of the mucosa, and the enteric nervous system. Although it is capable of operating independently from the central nervous system (CNS), the gut NES is connected to and modulated by the CNS. This review presents evidence for the presence of an anatomical defect in IBS patients, namely in the gastrointestinal endocrine cells. These cells have specialized microvilli that project into the lumen and function as sensors for the luminal content and respond to luminal stimuli by releasing hormones into the lamina propria, which starts a chain reaction that progresses throughout the entire NES. The changes in the gastrointestinal endocrine cells observed in IBS patients are highly consistent with the other abnormalities reported in IBS patients, such as visceral hypersensitivity, dysmotility, and abnormal secretion.

Entities:  

Keywords:  Cholecystokinin; Dysmotility; Endocrine cells; Enteric nervous system; Ghrelin; Peptide YY; Secretin; Secretion; Serotonin; Visceral hypersensitivity

Mesh:

Year:  2014        PMID: 24574708      PMCID: PMC3923014          DOI: 10.3748/wjg.v20.i2.384

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  320 in total

1.  Abnormal intestinal motility in irritable bowel syndrome.

Authors:  T Schmidt; A Pfeiffer; H Kaess
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

2.  Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo.

Authors:  A Souli; J Chariot; T Voisin; O Presset; A Tsocas; A Balasubramaniam; M Laburthe; C Rozé
Journal:  Peptides       Date:  1997       Impact factor: 3.750

Review 3.  Colonic myoelectric activity in the irritable bowel syndrome.

Authors:  W J Snape; G M Carlson; S Cohen
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

4.  Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact.

Authors:  Y Zhao; D Zou; R Wang; X Ma; X Yan; X Man; L Gao; J Fang; H Yan; X Kang; P Yin; Y Hao; Q Li; J Dent; J Sung; K Halling; B Wernersson; S Johansson; J He
Journal:  Aliment Pharmacol Ther       Date:  2010-05-22       Impact factor: 8.171

5.  Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats.

Authors:  Kazunori Fujino; Akio Inui; Akihiro Asakawa; Naoki Kihara; Masaki Fujimura; Mineko Fujimiya
Journal:  J Physiol       Date:  2003-07-01       Impact factor: 5.182

6.  Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis.

Authors:  L-H Wang; X-C Fang; G-Z Pan
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

7.  International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit.

Authors:  Douglas A Drossman; Carolyn Blank Morris; Susan Schneck; Yuming J B Hu; Nancy J Norton; William F Norton; Stephan R Weinland; Christine Dalton; Jane Leserman; Shrikant I Bangdiwala
Journal:  J Clin Gastroenterol       Date:  2009-07       Impact factor: 3.062

8.  Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and Japan.

Authors:  R J Schlemper; S D van der Werf; J P Vandenbroucke; I Biemond; C B Lamers
Journal:  Scand J Gastroenterol Suppl       Date:  1993

9.  The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.

Authors:  Kwang Jae Lee; Yeong Bae Kim; Jang Hee Kim; Hoek Chun Kwon; Dong Kyu Kim; Sung Won Cho
Journal:  J Gastroenterol Hepatol       Date:  2008-11       Impact factor: 4.029

10.  Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome.

Authors:  J Steens; P J Van Der Schaar; C Penning; J Brussee; A A M Masclee
Journal:  Neurogastroenterol Motil       Date:  2002-06       Impact factor: 3.598

View more
  40 in total

Review 1.  New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.

Authors:  Emanuele Sinagra; Gaetano Cristian Morreale; Ghazaleh Mohammadian; Giorgio Fusco; Valentina Guarnotta; Giovanni Tomasello; Francesco Cappello; Francesca Rossi; Georgios Amvrosiadis; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

Review 2.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

3.  Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome.

Authors:  Feng-yun Wang; Min Su; Yong-qiu Zheng; Xiao-ge Wang; Nan Kang; Ting Chen; En-lin Zhu; Zhao-xiang Bian; Xu-dong Tang
Journal:  Acta Pharmacol Sin       Date:  2015-05-11       Impact factor: 6.150

Review 4.  Recent developments in the pathophysiology of irritable bowel syndrome.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

5.  Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities.

Authors:  Magdy El-Salhy; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

6.  Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome.

Authors:  Magdy El-Salhy; Odd Helge Gilja; Doris Gundersen; Trygve Hausken
Journal:  World J Gastrointest Endosc       Date:  2014-05-16

7.  No More Pain in the Gut: Lifestyle Medicine Approach to Irritable Bowel Syndrome.

Authors:  Tereza Hubkova
Journal:  Am J Lifestyle Med       Date:  2017-02-11

Review 8.  The role of diet in the pathophysiology and management of irritable bowel syndrome.

Authors:  Magdy El-Salhy; Tanisa Patcharatrakul; Sutep Gonlachanvit
Journal:  Indian J Gastroenterol       Date:  2021-03-05

9.  The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.

Authors:  Tarek Mazzawi; Magdy El-Salhy; Gülen Arslan Lied; Trygve Hausken
Journal:  Front Cell Infect Microbiol       Date:  2021-05-12       Impact factor: 5.293

10.  Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century.

Authors:  Magdy El-Salhy; Tanisa Patcharatrakul; Sutep Gonlachanvit
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.